Basis: Trailing twelve months (TTM net income over the latest quarterly balance sheet). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on assets (ROA) high or low?
The return on assets (ROA) of -457.14% is in line with its 4-year average of -427.37%, around the middle of its 4-year range (-1098.50%–56.96%).
2.54% below its 12-month average of -445.84%.
Reported quarterly return on assets; no daily interpolation. Q2 FY2026 (2026-06-30): -121.88%.
RETURN ON ASSETS (ROA)
-457.14%
RETURN ON ASSETS (ROA) AVG TTM
-445.84%
RETURN ON ASSETS (ROA) AVG 3Y
-483.30%
RETURN ON ASSETS (ROA) AVG 5Y
N/A
RETURN ON ASSETS (ROA) AVG 10Y
N/A
RETURN ON ASSETS (ROA) AVG 15Y
N/A
RETURN ON ASSETS (ROA) AVG 20Y
N/A
CURRENT VS TTM AVG
-2.54%
CURRENT VS 3Y AVG
+5.41%
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-32.24%
median of 863 covered companies
CURRENT VS SECTOR MEDIAN
-1317.93%
vs the sector median at left
Tevogen Bio Holdings Inc.
Market Cap
$28.94M
Return on Assets (ROA)
-457.14%
TTM Avg
-445.84%
3Y Avg
-483.30%
5Y Avg
N/A
Market Cap
$29.24M
Return on Assets (ROA)
-49.53%
TTM Avg
-17.16%
3Y Avg
-133.18%
5Y Avg
-213.67%
Market Cap
$29.27M
Return on Assets (ROA)
-623.61%
TTM Avg
-201.00%
3Y Avg
-2514.84%
5Y Avg
-1875.48%
Market Cap
$29.37M
Return on Assets (ROA)
-102.56%
TTM Avg
-232.33%
3Y Avg
-191.42%
5Y Avg
-176.42%
Market Cap
$29.59M
Return on Assets (ROA)
-99.62%
TTM Avg
-39.99%
3Y Avg
-67.06%
5Y Avg
188.84%
Market Cap
$29.61M
Return on Assets (ROA)
-45.77%
TTM Avg
-31.61%
3Y Avg
-54.99%
5Y Avg
-58.45%
Market Cap
$27.86M
Return on Assets (ROA)
-87.08%
TTM Avg
-72.41%
3Y Avg
-58.48%
5Y Avg
-50.84%
Market Cap
$30.25M
Return on Assets (ROA)
-115.56%
TTM Avg
-181.38%
3Y Avg
-357.07%
5Y Avg
-299.51%
Market Cap
$30.37M
Return on Assets (ROA)
-116.76%
TTM Avg
-76.53%
3Y Avg
-78.60%
5Y Avg
-71.54%
| NAME | MARKET CAP | RETURN ON ASSETS (ROA) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Tevogen Bio Holdings Inc. (TVGN) | $28.94M | -457.14% | -445.84% | -483.30% | N/A |
| GridAI Technologies Corp. (GRDX)vs › | $29.24M | -49.53% | -17.16% | -133.18% | -213.67% |
| OneMedNet Corporation (ONMD)vs › | $29.27M | -623.61% | -201.00% | -2514.84% | -1875.48% |
| Quantum Cyber N.V. (QUCY)vs › | $29.37M | -102.56% | -232.33% | -191.42% | -176.42% |
| Context Therapeutics Inc. (CNTX)vs › | $29.59M | -99.62% | -39.99% | -67.06% | 188.84% |
| BeyondSpring Inc. (BYSI)vs › | $29.61M | -45.77% | -31.61% | -54.99% | -58.45% |
| aTyr Pharma, Inc. (ATYR)vs › | $27.86M | -87.08% | -72.41% | -58.48% | -50.84% |
| MIRA Pharmaceuticals, Inc. (MIRA)vs › | $30.25M | -115.56% | -181.38% | -357.07% | -299.51% |
| CervoMed Inc. (CRVO)vs › | $30.37M | -116.76% | -76.53% | -78.60% | -71.54% |
| MDxHealth S.A. (MDXH)vs › | $30.61M | -22.66% | -23.43% | -29.30% | -40.97% |
ROA
-457.1%
ROE
N/A
ROA = Net Income / Total Assets
Return on assets measures how efficiently a company generates profit from its total assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON ASSETS (ROA) |
|---|---|
| 2025-12-31 | -599.49% |
| 2024-12-31 | -292.18% |
| 2023-12-31 | -1098.50% |
| 2022-12-31 | 56.96% |
| 2021-12-31 | -203.66% |
